Vitamin D Supplementation in Hospitalized COVID-19 Patients
Providing Calcifediol (25-hydroxyvitamin D3) to COVID patients in this Pilot Study showed that it decreased the need for transfer to the intensive care unit. Let's take a look at why we shouldn't exactly put it in the water... yet.
Show Notes: https://eddyjoemd.com/vitamind-covid/
Receive a FREE audiobook (TWO for Amazon Prime members) with your FREE 30-day trial by using my link for Audible: CLICK HERE! You will be reminded when your trial is ending, by the way. 😉
Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.
My website: www.eddyjoemd.com
My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd
Castillo ME, Entrenas Costa LM, Vaquero Barrios JM, et al. "Effect of Calcifediol Treatment and best Available Therapy versus best Available Therapy on Intensive Care Unit Admission and Mortality Among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical study" [published online ahead of print, 2020 Aug 29]. J Steroid Biochem Mol Biol. 2020;105751. doi:10.1016/j.jsbmb.2020.105751
This episode is sponsored by
· Anchor: The easiest way to make a podcast. https://anchor.fm/app
Support this podcast: https://anchor.fm/eddyjoemd/support